Corcept Therapeutics Inc’s filing revealed that its Chief Business Officer Robb Gary Charles unloaded Company’s shares for reported $0.17 million on May 20 ’25. In the deal valued at $75.85 per share,2,279 shares were sold. As a result of this transaction, Robb Gary Charles now holds 16,586 shares worth roughly $1.27 million.
Then, Guyer William sold 32,262 shares, generating $2,393,014 in total proceeds. Upon selling the shares at $74.17, the Chief Development Officer now owns 5,487 shares.
Before that, MAHONEY DAVID L sold 27,352 shares. Corcept Therapeutics Inc shares valued at $2,030,452 were divested by the Director at a price of $74.23 per share. As a result of the transaction, MAHONEY DAVID L now holds 0 shares, worth roughly $0.0.
Truist upgraded its Corcept Therapeutics Inc [CORT] rating to a Buy from a a Hold in a research note published on November 06, 2023; the price target was increased to $38 from $29. A number of analysts have revised their coverage, including SVB Securities’s analysts, who began to cover the stock in mid April with a ‘”a Market perform”‘ rating. Piper Sandler began covering CORT with “an Overweight” recommendation on April 04, 2023. Jefferies revised its rating on February 15, 2023. It rated CORT as “a Hold” which previously was an “a Buy”.
Price Performance Review of CORT
On Tuesday, Corcept Therapeutics Inc [NASDAQ:CORT] saw its stock fall -2.39% to $76.81. Over the last five days, the stock has gained 2.66%. Corcept Therapeutics Inc shares have risen nearly 52.43% since the year began. Nevertheless, the stocks have risen 168.38% over the past one year. While a 52-week high of $117.33 was reached on 03/31/25, a 52-week low of $27.30 was recorded on 01/13/25. SMA at 50 days reached $70.30, while 200 days put it at $56.00.
Levels Of Support And Resistance For CORT Stock
The 24-hour chart illustrates a support level at 75.11, which if violated will result in even more drops to 73.40. On the upside, there is a resistance level at 79.58. A further resistance level may holdings at 82.35. The Relative Strength Index (RSI) on the 14-day chart is 58.40, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 3.45, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 32.53%. Stochastics %K at 83.95% indicates the stock is a selling.
